Economic Considerations of Macular Edema Therapies
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 118 (9) , 1827-1833
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal InsertOphthalmology, 2010
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Vitrectomy Outcomes in Eyes with Diabetic Macular Edema and Vitreomacular TractionOphthalmology, 2010
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyOphthalmology, 2009
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- Three-Year Follow-up of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular EdemaArchives of Ophthalmology (1950), 2009
- INTRAVITREAL BEVACIZUMAB INJECTIONS FOR TREATMENT OF CENTRAL RETINAL VEIN OCCLUSIONRetina, 2007
- Intravitreal Ranibizumab and Bevacizumab: A Review of RiskSeminars in Ophthalmology, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006